Leading cancer research centers reinforce importance of safe and effective HPV vaccination to prevent cancer
Today, Âé¶¹Ó³» MD Anderson Cancer Center, along with 61 National Cancer Institute (NCI)-Designated Cancer Centers, leading national organizations and the University of Puerto Rico Comprehensive...

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Novel tool helps identify key targets to strengthen CAR NK cell therapies
Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance
Cancer cells can break down...

MD Anderson awards top honors to exceptional faculty
HOUSTON ¨D Âé¶¹Ó³» MD Anderson Cancer Center honored more than 100 faculty members Thursday night during its annual Celebration...
MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments
MD Anderson ranked No. 1 in the nation for cancer care
MD Anderson announces 10th cohort of Andrew Sabin Family Fellows
HOUSTON ¨D Âé¶¹Ó³» MD?Anderson Cancer Center today announced its 10th cohort of Andrew Sabin Family Fellows, comprised...
Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later
New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers
Ovarian clear cell carcinoma is difficult to treat, and treatment options are limited
Patients with specific PPP2R1A mutations...